“It’s going to take some time to see how it’s going,” said Dr. John R. Cramer, a professor of medicine at the University of Michigan Health System in Ann Arbor who specializes in genetics and cancer.But Dr. Cramon said he believes the results of the study will be of benefit to clinicians who are working…